Is there a different impact of cyclosporine versus tacrolimus on delayed graft function after kidney transplantation?
Hanack
U
U
Klinik fur Transplantationschirurgie, Georg-August Universítat Gottingen, Germany.
Lorf
T
T
Braun
F
F
Grupp
C
C
Sattler
B
B
Binder
L
L
Müller
G A
GA
Ringe
B
B
D001379:Azathioprine / Q000627:therapeutic use; D016572:Cyclosporine / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D016030:Kidney Transplantation / Q000276:immunology / Q000502:physiology*; D009173:Mycophenolic Acid / Q000031:analogs & derivatives / Q000627:therapeutic use; D012189:Retrospective Studies; D016559:Tacrolimus / Q000627:therapeutic use*; D013997:Time Factors; D014661:Vasoconstriction / Q000187:drug effects; D014664:Vasodilation / Q000187:drug effects
D007166:Immunosuppressive Agents; D016572:Cyclosporine; D009173:Mycophenolic Acid; D001379:Azathioprine; D016559:Tacrolimus